Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diffusion and perfusion imaging biomarkers of H3 K27M mutation status in diffuse midline gliomas.

Neuroradiology - 1 Aug 2022

Kathrani Nihar, Chauhan Richa Singh, Kotwal Abhishek, Kulanthaivelu Karthik, Bhat Maya Dattatraya, Saini Jitender, Prasad Chandrajit, Chakrabarti Dhritiman, Santosh Vani, Uppar Alok Mohan, Srinivas Dwarakanath

Abstract excerpt

PURPOSE: H3K27M-mutant diffuse midline gliomas (M-DMGs) exhibit a clinically aggressive course. We studied diffusion-weighted imaging (DWI) and perfusion (PWI) MRI features of DMG with the hypothesis that DWI-PWI metrics can serve as biomarkers for the prediction of the H3K27M mutation status in DMGs. METHODS: A retrospective review of the institutional database (imaging and histopathology) of patients with DMG...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diffusion Magnetic Resonance Imaging

Share to Glioma

Share to Histones

Share to Mutation

Source

Identifiers

PMID: 35083503
DOI: 10.1007/s00234-021-02857-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diffusion and perfusion imaging biomarkers of H3 K27M mutation status in diffuse midline gliomas.PMID 35083503Read ↗

Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma.Semantic proximity Read ↗

Prediction of H3K27M mutation status of diffuse midline gliomas using MRI features.Semantic proximity Read ↗

Can Conventional MRI Features Predict H3K27M Mutation Status of Diffuse Midline Gliomas?Semantic proximity Read ↗

Clinical, qualitative imaging biomarkers, and tumor oxygenation imaging biomarkers for differentiation of midline-located IDH wild-type glioblastomas and H3 K27-altered diffuse midline gliomas in adults.Semantic proximity Read ↗

Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging.Semantic proximity Read ↗

Characteristics of H3K27M-mutant diffuse gliomas with a non-midline locationSemantic proximity Read ↗

Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity.Semantic proximity Read ↗

Clinico-pathological and molecular characterization of diffuse midline gliomas: is there a prognostic significance?Semantic proximity Read ↗

Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.Semantic proximity Read ↗

Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis.Semantic proximity Read ↗

Radiologic findings and the molecular expression profile of diffuse midline glioma H3 K27M mutant.Semantic proximity Read ↗

Multimodal MR imaging signatures to identify brain diffuse midline gliomas with H3 K27M mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.